Related Experiment Video
Updated: Jul 17, 2026

Intratracheal Administration of Dry Powder Formulation in Mice
Published on: July 25, 2020
Long acting porous microparticle for pulmonary protein delivery
Min Jung Kwon1, Jun Ho Bae, Jung Ju Kim
1Pharmaceutical and Health Research Institute, Amore Pacific Corporation/R&D Center, 314-1, Bora-dong, Giheung-gu, Yongin-si, Gyeonggi-do 446-729, Republic of Korea.
Abstract:
This study investigated the porous-microparticle (PM) with low mass density and large size for pulmonary drug delivery. PM was prepared by the water-in-oil-in-water (W(1)/O/W(2)) multi-emulsion method with cyclodextrin derivative as a porogen and a stabilizer of peptide drugs. Herein, sucrose ethyl acetate (SAIB) was incorporated in PM for long acting protein release. In vitro release studies, the rapid release rate of proteins from PM was reduced due to the high viscosity of the added SAIB. As a result, BSA release from PM continued up to 7 days. This result suggests that PM having sustained release characteristics may be successfully applied for long-term pulmonary administration of protein or peptide drug. In addition, it is expected that these particles arrive at a deep lung epithelium due to low density (high porosity) and limit macrophage recognition because of big particle size (more than 5 microm).
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Inhaled Medications

